Episode 133 - Ronald Li & James Kim - CEO and Chief Corporate at Medera respectively ficer at M episode artwork

EPISODE · Mar 19, 2026 · 23 MIN

Episode 133 - Ronald Li & James Kim - CEO and Chief Corporate at Medera respectively ficer at M

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

We were delighted to be joined by James Kim (Chief Corporate Officer) and Ronald Li (Chief Executive Officer), at Medera Biopharmaceuticals.Medera is a company at the forefront of pharmaceutical innovation, focused on advancing next-generation therapies and building a globally competitive platform across research, development, and commercialization. As the industry continues to evolve — driven by scientific breakthroughs, regulatory complexity, and shifting market dynamics — Medera is positioning itself to play a meaningful role in shaping what comes next.James and Ronald sit right at the center of that journey. Between them, they bring deep experience across strategy, operations, and scaling healthcare businesses, with a strong focus on translating innovation into real-world impact.

Episode metadata supplied by the publisher feed · Published Mar 19, 2026

Embed this episode

Ready to play

Episode 133 - Ronald Li & James Kim - CEO and Chief Corporate at Medera respectively ficer at M

0:00 23:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 23 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on March 19, 2026.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!